Related Experiment Videos
Surgical treatment of eyelid neurofibromas
Abstract:
The classical surgical treatment of eyelid neurofibromas has been careful dissection of the tumor with preservation of much of the surrounding abnormal lid tissues. The reported outcome has been uniformly unfavorable. These tumors infiltrate extensively and are impossible to dissect out completely. However, the lateral location of lid neurofibromas allows "en bloc" resection of most of the tumor including the adjacent involved lid tissues. Levator function in these cases is potentially good and the lid will elevate well if the levator aponeurosis is joined to the tarsus laterally at the time of surgery. The four cases presented here indicate that this procedure is technically easier and may produce more acceptable results than other forms of treatment.
Insights
Surgical treatment for eyelid neurofibromas can be improved. En bloc resection of lateral eyelid neurofibromas offers better outcomes than traditional dissection, preserving eyelid function.
Area of Science:
- Ophthalmology
- Surgical Oncology
- Plastic Surgery
Background:
- Classical surgical treatment for eyelid neurofibromas involves careful dissection, often with unfavorable outcomes due to extensive tumor infiltration.
- Complete tumor removal is challenging with traditional methods, leading to recurrence or suboptimal cosmetic and functional results.
Observation:
- Lateral eyelid neurofibromas present an opportunity for "en bloc" resection, including adjacent involved tissues.
- Preserving levator function is crucial for successful lid elevation post-surgery.
Findings:
- A novel surgical approach involving "en bloc" resection of lateral eyelid neurofibromas, with co-joining of the levator aponeurosis to the tarsus, was evaluated.
- This technique demonstrated technical ease and more acceptable results compared to conventional treatments in four presented cases.
Implications:
- This surgical strategy may offer a more effective treatment for lateral eyelid neurofibromas.
- Further research could validate this approach for improved patient outcomes in neurofibroma management.